Literature DB >> 16528207

Development of diffusion-weighted image using a 0.3T open MRI.

H Terada1, T Gomi, H Harada, T Chiba, T Nakamura, S Iwabuchi, H Nemoto, S Kawasaki, S Watanabe, M Nagamoto, Y Kawawa, E Kohda.   

Abstract

The purpose of this study was to develop a new technique for diffusion-weighted MRI (DWI) with a low-field scanner. DWI is becoming important for assessment of acute stroke. Until recently DWI required expensive technology. We developed multishot-DWI sequence for 0.3T open type MR imager. We prospectively studied forty patients on this 0.3T MRI and compared this DWI to single-shot-DWI by 1.5T-MRI. Group A: Twenty-four patients with acute cerebral infarctions detected by 1.5T-DWI were re-examined using 0.3T-DWI within 24 hours. Sixteen patients with acute cerebral infarctions detected by 0.3T-DWI were re-examined using 1.5T-DWI within 24 hours. In 22 (92%) of 24 cases, 0.3T-DWI showed high signal. In the other two patients, motion artifact distorted 0.3T-DWI. Group B: In all 16 patients, all infarctions detected by 0.3T-DWI showed high signal on 1.5T-DWI. These preliminary data show that, as long as the patient is able to keep still, multishot-DWI can be acquired successfully on a 0.3T open type MRI system.

Entities:  

Mesh:

Year:  2006        PMID: 16528207     DOI: 10.1016/s0150-9861(06)77229-7

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  2 in total

1.  Role of Diffusion-weighted Imaging in Acute Stroke Management using Low-field Magnetic Resonance Imaging in Resource-limited Settings.

Authors:  Chinonye K Okorie; Godwin I Ogbole; Mayowa O Owolabi; Olufunmilola Ogun; Abiodun Adeyinka; Adesola Ogunniyi
Journal:  West Afr J Radiol       Date:  2015-11-16

2.  Potential of Stroke Imaging Using a New Prototype of Low-Field MRI: A Prospective Direct 0.55 T/1.5 T Scanner Comparison.

Authors:  Thilo Rusche; Hanns-Christian Breit; Michael Bach; Jakob Wasserthal; Julian Gehweiler; Sebastian Manneck; Johanna Maria Lieb; Gian Marco De Marchis; Marios Nikos Psychogios; Peter B Sporns
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.